TVTX(TVTX)
TVTX
ANALYST COVERAGE18 analysts
BUY
▲ +19.5%upside to target
L $49.00
Med $51.50consensus
H $54.00PRICE
Prev Close
42.59
Open
42.82
Day Range42.10 – 43.28
42.10
43.28
52W Range13.88 – 48.61
13.88
48.61
84% of range
VOLUME & SIZE
Avg Volume
2.1M
FUNDAMENTALS
P/E Ratio
-86.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.02
Market-like
TECHNICAL
RSI (14)
69
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 91 days
Aug 17
Key MetricsTTM
Market Cap$4.00B
Revenue TTM$536.20M
Net Income TTM-$21.42M
Free Cash Flow$17.43M
Gross Margin94.0%
Operating Margin-10.6%
Net Margin-4.0%
Return on Equity-26.8%
Return on Assets-3.9%
Debt / Equity3.32
Current Ratio3.13
EPS TTM$-0.23
TVTX News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Christopher ClineChief Financial Officer
Peter HeermaChief Commercial Officer
Angela GiannantonioChief People Officer
Charlotte SmithChief Corporate Affairs Officer
Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary
Nivi NehraVice President of Corporate Communications & Investor Relations
Sandra CalvinSVP, Corporate Controller & Chief Accounting Officer
Eric DubePresident, Chief Executive Officer & Director
Jula InrigChief Medical Officer
William E. RoteChief Research Officer
Casey LoganChief Business Officer